NetworkNewsBreaks – Zenosense, Inc. (ZENO) MML J
Post# of 53
(Total Views: 168)
Posted On: 10/02/2018 6:05:40 PM
NetworkNewsBreaks – Zenosense, Inc. (ZENO) MML JV Expands Technical Team
Healthcare technology company Zenosense (OTC: ZENO) this morning announced that, in support of the next phase of development of MIDS Cardiac, its MIDS Medical Ltd. (“MML”) joint venture (“JV”) has expanded its technical team. MML has engaged three key contractors following its recent funding agreement. Two such contractors are independent electronics engineers with experience including embedded digital and analogue hardware and software design, multilayer PC design, immunoassay and magnetic particle experience, control systems and data acquisition. Additionally, MML has engaged The Magnetism Group at the University of Liverpool led by Dr. Liam O’Brien, which will assist MML in the calibration and development of its medical diagnostic technologies.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Healthcare technology company Zenosense (OTC: ZENO) this morning announced that, in support of the next phase of development of MIDS Cardiac, its MIDS Medical Ltd. (“MML”) joint venture (“JV”) has expanded its technical team. MML has engaged three key contractors following its recent funding agreement. Two such contractors are independent electronics engineers with experience including embedded digital and analogue hardware and software design, multilayer PC design, immunoassay and magnetic particle experience, control systems and data acquisition. Additionally, MML has engaged The Magnetism Group at the University of Liverpool led by Dr. Liam O’Brien, which will assist MML in the calibration and development of its medical diagnostic technologies.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)